FDA DEVICE FACTS
EchoMD Automated Ejection Fraction Software
Bay Labs, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Bay Labs, Inc. EchoMD Automated Ejection Fraction software is used to process previously acquired transthoracic cardiac ultrasound images, to store images, and to manipulate and make measurements on images using a personal computer or a compatible DICOM-compliant PACS system in order to provide automated estimation of left ventricular ejection fraction. This measurement can be used to assist the clinician in a cardiac evaluation. The EchoMD Automated Ejection Fraction Software Application is indicated for use in adult patients. The intended use/indications for use statement is worded slightly differently than that of the predicate device, but the minor differences do not alter the intended diagnostic effect of the subject device; both products are intended to process echocardiogram images and produce ejection fraction calculations. The minor differences also do not raise different questions of safety or effectiveness, as in both instances the key question is whether the software can both produce ejection fraction calculations acceptable for clinical use.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。